Organisation paid for research Program year 2025 Source: CMS Open Payments

Apex Trials Group

Neither a doctor nor a teaching hospital

Research payments

$92,971

210 payments

Through program year 2025, Apex Trials Group is reported as receiving $92,971 in research payments, across 210 payments.

By program year

4 rows

Year	Kind	Amount	Payments
2025	Research	$95	2
2024	Research	$82,151	108
2023	Research	$1,735	31
2019	Research	$8,990	69

Breakdown

Who paid Research payments · program years 2019–2025

Argenx US, Inc. $83,981 141 payments
Biotronik Inc. $8,990 69 payments

Studies the money was for Research payments · program years 2019–2025

Quincy Model - Open-Label Extension Study to Evaluate the Long term Safety and Efficacy of Efgartigimod in Adult Patients with Post-COVID-19 Postural Orthostatic Tachycardia Syndrome (PC-POTS) who Completed Study ARGX 113-2104 $39,199 46 payments
Quincy Model - A phase 2 randomized, double-blinded, placebo-controlled study to evaluate the efficacy and safety of efgartigimod IV in adult patients with postCOVID-19 postural orthostatic tachycardia syndrome (POTS) $23,794 54 payments
A Phase 3, Multicenter, Randomized, Double-Blinded, Placebo-Controlled Trial to Evaluate the Efficacy and the Safety of Efgartigimod (ARGX-113) PH20 Subcutaneous in Adult Patients With Primary Immune Thrombocytopenia $20,988 41 payments
QP ExCELs $8,990 69 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.